Table 1.

Patient demographics (N = 301)

	N
Gender
Male	142 (47%)
Female	159 (53%)
Stage at diagnosis
Localized	236 (78%)
Metastatic	64 (21%)
Not available	1 (1%)
Sarcoma subtype
L-sarcomas	167 (55%)
Leiomyosarcoma	92 (31%)
Myxoid liposarcoma	37 (12%)
Dedifferentiated liposarcoma	22 (7%)
Well-differentiated liposarcoma	13 (4%)
Pleomorphic liposarcoma	3 (1%)
Non-L-sarcomas	134 (45%)
Synovial sarcoma	28 (9%)
Undifferentiated pleomorphic sarcoma	28 (9%)
Sarcoma NOS (not otherwise specified)	16 (6%)
Malignant peripheral nerve sheath tumor	15 (5%)
Other subtypes	47 (16%)
Grade
1	39 (13%)
2	70 (23%)
3	167 (56%)
Not available	25 (8%)
Median follow-up from diagnostic (months)	41
Median follow-up from trabectedin line (months)	11
Median age, years (range)	51 (14–79)